维普中文期刊产品整合服务
376篇 您的检索式:作者名="Hayes DF"
    题名 作者 年代 出处 被引量
1HER2 and response to paelitaxel in node-positive breast cancer显示文摘Hayes DF Thor AD Dressier l G 2007N Engl J Med2007,357,15:1
2The impact of postnatal depression on boys'intellectual development 显示文摘Sharp D Hay DF Pawlby S 1995J Child Psycol Psychiatry1995,36,8:1
3A tumor marker util- ity grading system (TMUGS): a framework evaluate clinical utility of tumor markers显示文摘HAYES DF BAST R DESCH CE 1996J Natl Can Inst1996,88,20:1
4CA15-3and CEA spikes during chemotherapy for metastatic breast cancer显示文摘Hayes DF Kiang DT Korzum AH 1998Proc Am Soc Clin Oncol1998,7,:1
5When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer显示文摘Yamauchi H Stearns V Hayes DF 2001J Clin Oncol2001,159,8:1
6Circulating Her2/erbB2/c neu(Her2) extracellular domain as a prognostic factor in patients with metastatic breast cancer :cancer and leukemia group B study 8662显示文摘Hayes DF Yamauchi H Broadwater G 2001Clin Cancer Res2001,7,9:1
7c-erbB-2 in breast cancer:development of a clinically useful marker显示文摘Hayes DF Thor AD 2002Semin Oncol2002,29,3:1
82000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology显示文摘Bast RC Jr Ravdin P Hayes DF 2001J Clin Oncol2001,19,6:1
9HER - 2 predicts benefit from adjuvant paclitaxel after AC in node - positive breast cancer CALG B 9344 显示文摘Hayes DF Thor A Dressier I 2006Pr oc Am Soc Clin Oneol2006,24,18:1
10Review of preoperative magnetic resonance imaging(MRI)in breast cancer:should MRI be performed on all women with newly diagnosed,early stage breast cancer显示文摘Houssami N Hayes DF 0,,:1
11American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version) 显示文摘Hammond MEH Hayes DF Dowsett M 2010Arch Pathol Lab Med2010,134,7:1
12Circulating Her-2/C- erbB-2/neu ( Her-2 ) extraceUular domain as a prognostic factor in patients with metastatic breast cancer: cancer and leukemia group B study 8662显示文摘Hayes DF Yamauehi H Broadwater G 2001Clin Cancer Res2001,7,9:1
13When is a tumor marker ready for prime time ? A case study of C-erbB-2 as a predictive factor in breast cancer显示文摘Yamauchi H Stearns V Hayes DF 2001J Clin Oncol2001,19,:1
14c-erbB-2 in breast cancer:Development of a clinically useful marker显示文摘Hayes DF Thor AD 2002Semin Oncol2002,29,3:1
15The left atrioventricular valve in partial atrioventricular septal defect: management strategy and surgical outcome显示文摘Al - Hay AA Lincoln CR Shore DF 2004Eur J Cardiothorac Surg2004,26,4:1
162000 update of recommen- dations for the use of tumor markers in breast and colorectal can- cer:clinical practice guidelines of the American Society of Clini- cal Oncology显示文摘Bast RC Jr Ravdin P Hayes DF 2001J Clin Oncol2001,19,6:1
17Assessing the clinical impact of prognostic factors:when is ' stastistically significant 'clinically useful显示文摘Hayes DF Trock B Harris A 1998Breast Cancer Res Treat1998,52,3:1
18American society of clinical oncology/college of american pathologists guideline recom- mendations for immunohistochemical testing of estrogen and proges- terone receptors in breast eaneer 显示文摘Hammond ME Hayes DF Dowser M 2010Arch Pathol Lab Med2010,134,6:1
19American Society of Clinical Oneology/College Of American Pathologists guideline rec- ommendations for immunohistochemieal testing of estrogen and pro- gesterone receptors in breast cancer 显示文摘Hammond ME Hayes DF Dowsett M 2010J Clin Onco2010,28,16:1
20Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage Ⅰ or Ⅱ breast cancer 显示文摘Nixon AJ Neuberg D Hayes DF 1994J Clin Oncol1994,12,5:1
返回顶部 每页显示:
共19页 首页 上一页 第1页 下一页 末页 /19 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费